Accretion Nutraveda – IPO
Accretion Nutraveda – IPO Details
| IPO Date | January 27, 2026 to January 30, 2026 |
| Listing Date | February 4, 2026 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 122 to ₹ 129 / Share |
| Lot Size | 1000 Shares |
| Total Issue Size | 19,20,000 shares (Aggregating up to ₹25 Cr) |
| Fresh Issue | |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share holding pre issue | 53,20,000 shares |
| Share holding post issue | 72,40,000 shares |
| Market Maker portion |
Accretion Nutraveda Timeline (Tentative Schedule)
Accretion Nutraveda IPO opens on January 27, 2026, and closes on January 30, 2026.
| IPO Open Date | January 27, 2026 |
| IPO Close Date | January 30, 2026 |
| Basis of Allotment | February 2, 2026 |
| Initiation of Refunds | February 3, 2026 |
| Credit of Shares to Demat | February 3, 2026 |
| Listing Date | February 4, 2026 |
| Cut-off time for UPI mandate confirmation | -- |
Accretion Nutraveda IPO Lot Size
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | Rs.258,000 |
| Retail (Max) | 2 | 2,000 | Rs.258,000 |
| S-HNI (Min) | 3 | 3,000 | Rs.387,000 |
| S-HNI (Max) | 7 | 7,000 | Rs.903,000 |
| B-HNI (Min) | 8 | 8,000 | Rs.1,032,000 |
| HNI (Min) |
Accretion Nutraveda IPO Promoter Holding
| Share Holding Pre Issue | 100% |
| Share Holding Post Issue | 73.48% |
Accretion Nutraveda IPO Reservation
Accretion Nutraveda IPO offers a total of 19,20,000 shares. Out of which 9,08,000 (47.29%) allocated to QIB, 2,76,000 (14.37%) allocated to NII, and 6,40,000 (33.33%) allocated to RII.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | 96,000 (5.00%) |
|
| Other Shares Offered | |
|
| QIB Shares Offered | 9,08,000 (47.29%) |
|
| NII (HNI) Shares Offered | 2,76,000 (14.37%) |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | 6,40,000 (33.33%) |
|
| Employee Shares Offered | |
|
| Total Shares Offered | 19,20,000 (100.00%) |
Accretion Nutraveda IPO Anchor Investors Details
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
About Accretion Nutraveda
Accretion Nutraveda is a company that was officially registered in 2021 and is involved in the production of Ayurvedic and Nutraceutical products in different types of dosage, such as tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.
The company has been functioning as a Contract Development and Manufacturing Organization (CDMO) that has been supplying the domestic markets as well as foreign markets like Sri Lanka, Singapore, and the USA. Its products are a blend of classical Ayurvedic principles and modern nutraceutical science and they are targeted at liver care, womens health, bone and joint health, cognitive support, and respiratory wellness.
Business verticals:
Domestic Sales & Merchant Exports (Loan License Basis) Account for 96. 62% of total revenue in FY 2024, 25.
Direct Exports Up to 38%, with a steady increase.
The companys factory in Gujarat is spread over a space of about 10, 763 sq. ft. , furnished with state, of, the, art facilities, such as 13 air handling units, separate processing areas, and quality control systems. The factory is GMP, WHO, GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified, with an FSSAI license.
Competencies:
Experienced promoters and management Team
Wide range of product portfolio
Quality control and standards
Established client, supplier relationships
Developed business process and management framework
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 81.22% |
| ROCE | 36.98% |
| Debt/Equity | 0.72 |
| RoNW | 48.85% |
| P/BV | 8.76 |
| PAT Margin (%) | 16.33% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.91 | 3.61 |
| P/E (x) | 26.27 | 35.75 |
Note:
- The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
- The Pre IPO EPS is calculated based on Pre issue shareholding as on the date of RHP and the latest FY earnings as of March 31, 2025, available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of March 31, 2025, available in RHP.
Objects of the Issue (Accretion Nutraveda IPO Objectives)
Accretion Nutraveda Contact Details
Accretion Nutraveda Ltd 27 Xcelon Industrial Park-1 Vasna-Chacharwadi, TaSanand, Ahmedabad, Gujarat, 382213
|
Accretion Nutraveda IPO Registrar
Kfin Technologies Ltd.
|